Life Edit, an ElevateBio company, is a next-generation genome editing company that has built a highly innovative platform with one of the world’s largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The platform allows Life Edit to target any genomic sequence and develop novel human therapeutics for the most challenging genetic diseases by enabling ex vivo engineering for cell therapies and regenerative medicines and in vivo delivery of gene therapies. In addition to developing its own pipeline of cell and gene therapies, Life Edit Therapeutics will continue to strengthen its platform of genome-editing enzymes, provide gene-editing expertise to strategic partners, and form other third-party partnerships to discover and develop new therapies. 

Therapeutics

Life Sciences

Life Edit Therapeutics

David Hallal

Missy Kotchey

Kathryn Woodburn

Joel Parker

Hélène Svahnqvist

Clare Murray

Bhakti Bhargava

Tedd Elich

The Leadership Team at Life Edit Therapeutics is responsible for steering the company's strategic direction, ensuring the advancement of its genome-editing platform, and driving the development of novel therapeutic pipelines. This team oversees key operations, forms strategic partnerships, and maintains corporate governance to achieve the company’s mission of addressing challenging genetic diseases.

Leadership Team

Scientific Research Team

Development Team

Leadership Team

About

Team members

Other teams at Life Edit Therapeutics

Scientific Research Team

Development Team